Strides Arcolab to increase FII investment limits up to 74%

05 Aug 2013 Evaluate

Strides Arcolab has received an approval to increase the Foreign Institutional Investors (FII) investment limit in the company. FII’s can now invest up to 74% of the paid up equity share capital of the company under the Portfolio Investment Scheme. The current FII holding in the company is 52%.

The shareholders of the company at their Extraordinary General Meeting held on August 03, 2013, have approved for the same. As required under the FEMA Regulation, the company has made necessary intimation to the Reserve Bank of India confirming the shareholders’ approval for the increased FII investment limit.

Strides Arcolab is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures wide range of IP-lead niche pharmaceutical products with an emphasis on sterile injectables.

Strides Pharma Scien Share Price

796.20 -68.60 (-7.93%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×